Latest filing published 07 Oct 2025 for GlucoTrack, Inc..
No signal scores available.
Erin Catherine Carter discloses dealings in GlucoTrack, Inc. to SEC (Form 4). Between 31 December 2023 and 3 October 2025, the trades on record add up to 8 filings.
Not one of the filings records a straightforward purchase or sale on the market. Grants and option exercises follow pay plans set in advance, so they reveal less about an insider's own view than a purchase made with personal money.
Most recently, on 7 October 2025, the filings show a share grant in GlucoTrack, Inc. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
4 of 4 declarations